Detalles de la búsqueda
1.
The Effects of Antipsychotics on the Synaptic Plasticity Gene Homer1a Depend on a Combination of Their Receptor Profile, Dose, Duration of Treatment, and Brain Regions Targeted.
Int J Mol Sci;
21(15)2020 Aug 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-32756473
2.
Perinatal stress modulates glutamatergic functional connectivity: A post-synaptic density immediate early gene-based network analysis.
Prog Neuropsychopharmacol Biol Psychiatry;
133: 111032, 2024 Jul 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-38762163
3.
Dopamine Dynamics and Neurobiology of Non-Response to Antipsychotics, Relevance for Treatment Resistant Schizophrenia: A Systematic Review and Critical Appraisal.
Biomedicines;
11(3)2023 Mar 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-36979877
4.
Disorganization domain as a putative predictor of Treatment Resistant Schizophrenia (TRS) diagnosis: A machine learning approach.
J Psychiatr Res;
155: 572-578, 2022 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-36206601
5.
Relationships between early age at onset of psychotic symptoms and treatment resistant schizophrenia.
Early Interv Psychiatry;
16(4): 352-362, 2022 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-33998142
6.
Modulation of glutamatergic functional connectivity by a prototypical antipsychotic: Translational inference from a postsynaptic density immediate-early gene-based network analysis.
Behav Brain Res;
404: 113160, 2021 04 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-33577880
7.
Synthesis and Preclinical Evaluation of 6-[18F]Fluorine-α-methyl-l-tryptophan, a Novel PET Tracer for Measuring Tryptophan Uptake.
ACS Chem Neurosci;
11(12): 1756-1761, 2020 06 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-32343551
8.
Glutamatergic postsynaptic density in early life stress programming: Topographic gene expression of mGlu5 receptors and Homer proteins.
Prog Neuropsychopharmacol Biol Psychiatry;
96: 109725, 2020 01 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-31404590
9.
Translating preclinical findings in clinically relevant new antipsychotic targets: focus on the glutamatergic postsynaptic density. Implications for treatment resistant schizophrenia.
Neurosci Biobehav Rev;
107: 795-827, 2019 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-31461641
10.
Treatment resistant schizophrenia and neurological soft signs may converge on the same pathology: Evidence from explanatory analysis on clinical, psychopathological, and cognitive variables.
Prog Neuropsychopharmacol Biol Psychiatry;
81: 356-366, 2018 Feb 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-28887181
11.
Evaluation of a few discrete clinical markers may predict categorization of actively symptomatic non-acute schizophrenia patients as treatment resistant or responders: A study by ROC curve analysis and multivariate analyses.
Psychiatry Res;
269: 481-493, 2018 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-30195742
12.
Disease Severity in Treatment Resistant Schizophrenia Patients Is Mainly Affected by Negative Symptoms, Which Mediate the Effects of Cognitive Dysfunctions and Neurological Soft Signs.
Front Psychiatry;
9: 553, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-30429802
13.
Re-arrangements of gene transcripts at glutamatergic synapses after prolonged treatments with antipsychotics: A putative link with synaptic remodeling.
Prog Neuropsychopharmacol Biol Psychiatry;
76: 29-41, 2017 06 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-28235555
Resultados
1 -
13
de 13
1
Próxima >
>>